Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Amer H. Zureikat"'
Autor:
Samer AlMasri, Mazen Zenati, Abdulrahman Hammad, Ibrahim Nassour, Hao Liu, Melissa E. Hogg, Herbert J. Zeh, Brian Boone, Nathan Bahary, Aatur D. Singhi, Kenneth K. Lee, Alessandro Paniccia, Amer H. Zureikat
Publikováno v:
JAMA Network Open. 5:e2218355
Neoadjuvant therapy is increasingly used in localized pancreatic carcinoma, and survival is correlated with carbohydrate antigen 19-9 (CA19-9) levels and histopathologic response following neoadjuvant therapy. With several regimens now available, the
Autor:
Johanna E. Bellon, L. Mark Knab, Amr I. Al Abbas, Ahmad Hamad, Amer H. Zureikat, Herbert J. Zeh, Jacob C. Hodges, Melissa E. Hogg, A. James Moser, Jeffrey D. Borrebach, MaryJoe Rice
Publikováno v:
JAMA Surgery. 155:607
Learning curves are unavoidable for practicing surgeons when adopting new technologies. However, patient outcomes are worse in the early stages of a learning curve vs after mastery. Therefore, it is critical to find a way to decrease these learning c
Autor:
John Aversa, Thomas F. Seykora, Elijah Dixon, Stephen W. Behrman, Amer H. Zureikat, Stacy J. Kowalsky, Adam C. Berger, Roberto Salvia, Tara S. Kent, Valentina Allegrini, Martha Navarro Cagigas, Michael G. House, Chad G. Ball, Robert H. Hollis, Paxton V. Dickson, Mollie R. Freedman-Weiss, William E. Fisher, Courtney E. Barrows, Brett L. Ecker, Carl Schmidt, Francisco Guzman-Pruneda, Charles M. Vollmer, Giuseppe Malleo, John D. Christein, Ronald R. Salem, Richard Zheng
Publikováno v:
Hepatobiliary Surg Nutr
Importance Ampullary adenocarcinoma is a rare malignant neoplasm that arises within the duodenal ampullary complex. The role of adjuvant therapy (AT) in the treatment of ampullary adenocarcinoma has not been clearly defined. Objective To determine if
Autor:
Melissa E. Hogg, Charles M. Vollmer, Herbert J. Zeh, Stacy J. Kowalsky, Matthew T. McMillan, Amer H. Zureikat, Michael H. Sprys
Publikováno v:
JAMA Surgery. 152:327
The adoption of robotic pancreatoduodenectomy (RPD) is gaining momentum; however, its impact on major outcomes, including pancreatic fistula, has yet to be adequately compared with open pancreatoduodenectomy (OPD).To demonstrate that use of RPD does
Autor:
Haroon A. Choudry, Steven J. Hughes, Kenneth K.W. Lee, William E. Gooding, Alyssa M. Krasinskas, Herbert J. Zeh, Jennifer L. Steel, A. James Moser, Mustapha Daouadi, Jennifer Steve, Deepa Magge, Amer H. Zureikat
Publikováno v:
JAMA Surgery. 148:525
Importance Multicenter studies indicate that outcomes of open (ODP) and minimally invasive distal pancreatectomy (MIDP) are equivalent for benign lesions. However, data for pancreatic carcinoma are limited. Objective To compare outcomes of ODP and MI